GlaxoSmithKline PLC Stock Target Price and Analyst Consensus
| GSK Stock | USD 36.31 0.16 0.44% |
The current analyst and expert consensus on GlaxoSmithKline PLC is Hold with 5 hold recommendations. The current projected GlaxoSmithKline PLC target price consensus is 41.54 with 8 analyst opinions. One of the most common ways GlaxoSmithKline PLC ADR analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to GlaxoSmithKline PLC vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on GlaxoSmithKline PLC. We strongly encourage you to use your own analysis of GlaxoSmithKline PLC ADR to validate this buy or sell advice. GlaxoSmithKline PLC recommendation module provides expert sentiment on the projected GlaxoSmithKline PLC ADR target price to derive its highest and lowest estimates based on target price standard deviation of 1.7264.
Lowest Forecast 37.8 | Highest Forecast 46.1 | Target Price 41.54 |
GlaxoSmithKline | Build AI portfolio with GlaxoSmithKline Stock |
It's important to approach GlaxoSmithKline PLC's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize GlaxoSmithKline PLC price targets
GlaxoSmithKline PLC's stock target price is an estimate of its future price, usually made by analysts. Using GlaxoSmithKline PLC's target price to determine if it is a suitable investment can be done through the following steps:- Look at GlaxoSmithKline PLC's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if GlaxoSmithKline PLC's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional GlaxoSmithKline PLC Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of GlaxoSmithKline PLC is a key component of GlaxoSmithKline PLC valuation and have some predictive power on the future returns of a GlaxoSmithKline PLC.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | FinTech Invested over 30 shares | |
 | Investor Favorites Invested few shares | |
 | Business Services Invested few shares | |
 | Chemicals Invested over 40 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Momentum Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Cash Cows Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Banking Invested over 40 shares | |
 | Artificial Intelligence Invested few shares | |
 | Driverless Cars Invested over 50 shares |
Check out Macroaxis Advice on GlaxoSmithKline PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..